Eli Lilly: A Wonderful Company, But A Stock Priced For Perfection

My followers may notice that I wrote this prior article to compare Eli Lilly ( LLY ) against its archrival Novo Nordisk ( NVO ), as well as their Big Pharma industry peers, byI run my own boutique law firm, focusing on investment transactions and disputes. Trained at top U.S. law schools and leading Wall Street law firms, I write here primarily to sharpen my own thinking and to engage with my followers. I endeavor to respond to any substantive comments on my articles. My goal is to identify potential 5–10 b ...